Repository logo
 

Managing multiple and extensively drug-resistant tuberculosis and HIV.

dc.contributor.authorPadayatchi, Nesri.
dc.contributor.authorFriedland, Gerald H.
dc.date.accessioned2013-05-21T10:26:25Z
dc.date.available2013-05-21T10:26:25Z
dc.date.created2007
dc.date.issued2007
dc.description.abstractGlobal increases in multi-drug-resistant and extensively drug-resistant tuberculosis (TB), are threatening both TB and HIV treatment programs worldwide. Together, they raise concerns of a global epidemic of untreatable TB. In the developing world, the directly observed treatment, short course (DOTS) strategy is proving ineffective as available resources are being outstripped by the large number of patients needing treatment. Thus, TB treatment and outcomes are sub-optimal, and multi-drug resistant and extensively drug-resistant TB are on the rise.en
dc.identifier.citationPadayatchi, N., Friedland, G. 2007. Managing multiple and extensively drug-resistant tuberculosis and HIV. Expert Opin. Pharmacother. 8(8) pp. 1035-1037.en
dc.identifier.issn1465-6566
dc.identifier.urihttp://dx.doi.org/10.1517/14656566.8.8.1035en
dc.identifier.urihttp://hdl.handle.net/10413/8948
dc.language.isoenen
dc.publisherInforma Healthcare.en
dc.subjectMultidrug-resistant tuberculosis.en
dc.subjectMultidrug-resistant tuberculosis--Treatment.en
dc.subjectHIV infections--Treatment.en
dc.subjectDirectly observed therapy (Program)en
dc.subject.otherMDR-TB.en
dc.subject.otherXDR-TB.en
dc.subject.otherExtensively drug-resistant tuberculosis.en
dc.subject.otherTuberculosis directly observed therapy.en
dc.subject.otherDOTS.en
dc.titleManaging multiple and extensively drug-resistant tuberculosis and HIV.en
dc.typePeer reviewed journal articleen

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Padayatchi_Nesri_2007.pdf
Size:
411.11 KB
Format:
Adobe Portable Document Format
Description:
Journal article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.64 KB
Format:
Item-specific license agreed upon to submission
Description: